The people on this site are members of the Rituxan Ambassador Program, which is sponsored by Genentech USA, Inc. and Biogen. Genentech compensates the Ambassadors for their time and expense while presenting their stories.

Rituxan with glucocorticoids is the only FDA-approved induction treatment for adults with Granulomatosis with Polyangiitis (GPA) (formerly known as Wegener's Granulomatosis) and Microscopic Polyangiitis (MPA)

*In a clinical trial for Rituxan, "complete remission" was defined as no disease activity and being able to stop steroids by 6 months.